Hypothalamic Obesity

Also known as: Central Diabetes Insipidus / Diabetes Insipidus, Neurogenic / Hypothalamic Injury-induced Obesity (HIO) / Vasopressin deficiency / Neurohypophyseal diabetes insipidus (disorder) / Antidiuretic hormone deficiency / Pituitary diabetes insipidus / Hypothalamic obesity (disorder) / Diabetes insipidus / Diabetes insipidus (disorder)

DrugDrug NameDrug Description
DB00035DesmopressinA synthetic analog of vasopressin used to reduce renal excretion of water in central diabetes insipidus and nocturia.
DrugDrug NamePhaseStatusCount
DB06655Liraglutide0Recruiting1
DB00107Oxytocin1Not Yet Recruiting1
DB01276Exenatide1 / 2Completed1
DB01119Diazoxide2Completed1
DB18331LB546402Not Yet Recruiting1
DB00331Metformin2Completed1
DB00264Metoprolol2Completed1
DB00264Metoprolol2Withdrawn1
DB00107Oxytocin2Completed1
DB00191Phentermine2Not Yet Recruiting1
DB11700Setmelanotide2Completed1
DB06156Tesofensine2Completed1
DB06156Tesofensine2Withdrawn1
DB00273Topiramate2Not Yet Recruiting1
DB00035Desmopressin3Completed1
DB01276Exenatide3Completed2
DB11700Setmelanotide3Enrolling by Invitation1
DB01276Exenatide4Recruiting1
DB00104Octreotide4Completed1
DB01276ExenatideNot AvailableUnknown Status1